Expertise in
1
conditions

Masahiro Kashiwaba

208 Iju, Nakagusuku Village, Nakagami District, 
Okinawa, JP 
Expertise in
1
conditions
208 Iju, Nakagusuku Village, Nakagami District, 
Okinawa, JP 

Overview

Masahiro Kashiwaba practices practicing medicine in Okinawa, Japan.

Mr. Kashiwaba is highly rated in 1 condition, according to our data. His clinical expertise encompasses Breast Cancer, HER-2 Positive Breast Cancer, Gastrointestinal Perforation, Peripheral Neuropathy, and Mastectomy.

He is actively involved in clinical research, co-authoring 45 peer reviewed articles and participating in 1 clinical trial.

Gender

Male

Locations

208 Iju, Nakagusuku Village, Nakagami District, Okinawa, 9012492, Japan
Other Locations
Miyazaki, Japan
Matsubara, 8920098, Japan
Kyoto, 6038052, Japan
Kagoshima, Japan
Morioka, Japan
Japan

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Phase III Randomized, Double-Blind, Neoadjuvant Study of Hormonal Therapy Plus Palbociclib Versus Hormonal Therapy Plus Placebo in Women With Operable, Hormone Sensitive and HER2-Negative Primary Breast Cancer
A Phase III Randomized, Double-Blind, Neoadjuvant Study of Hormonal Therapy Plus Palbociclib Versus Hormonal Therapy Plus Placebo in Women With Operable, Hormone Sensitive and HER2-Negative Primary Breast Cancer
Enrollment Status: Completed
Publish Date: March 10, 2023
Intervention Type: Drug
Study Drugs: Palbociclib, Endocrine Therapy
Study Phase: Phase 3

45 Total Publications

Prognosis of ER-positive, HER2-negative postmenopausal early breast cancer patients based on response to neoadjuvant endocrine therapy and multigene assay results: findings from the NEOS trial.
Prognosis of ER-positive, HER2-negative postmenopausal early breast cancer patients based on response to neoadjuvant endocrine therapy and multigene assay results: findings from the NEOS trial.
Journal: Breast cancer (Tokyo, Japan)
Published: January 27, 2026

Frequently Asked Questions about Masahiro Kashiwaba

Is Masahiro Kashiwaba a top-rated expert for Breast Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Masahiro Kashiwaba is classified as an Distinguished expert for Breast Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Masahiro Kashiwaba participate in research or clinical trials?

Yes. Masahiro Kashiwaba has published 45 articles and abstracts on conditions like Breast Cancer. You can view a list of Masahiro Kashiwaba's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Kashiwaba's expertise for a condition
ConditionClose
      View All 8 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile